Visiongain has launched a new pharma report ‘’Nuclear Medicine Market Report 2020-2030’’ by type {Diagnostic Nuclear Medicine (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes)}, Application {Diagnostic Applications (PET Applications, SPECT Applications), Therapeutic Applications (Bone Metastasis, Endocrine Tumors, Lymphoma, Thyroid, Other Therapeutic Applications)}, and Geography.

To read more please visit:

https://www.visiongain.com/global-nuclear-medicine-market-is-anticipated-to-reach-usd-20-96-billion-by-2030-says-visiongain/

Source: VisionGain